• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

Introduction to 5-Acetyl-3-aminoiminodibenzyl (CAS No. 84803-67-8)

5-Acetyl-3-aminoiminodibenzyl, identified by its Chemical Abstracts Service (CAS) number 84803-67-8, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, featuring a dibenzyl core with functional groups including an acetyl and an aminoimine moiety, exhibits unique structural and chemical properties that make it a valuable scaffold for the development of novel bioactive molecules.

The molecular structure of 5-Acetyl-3-aminoiminodibenzyl consists of two benzyl rings linked by an amine group, with an acetyl substituent at the 5-position and an aminoimine group at the 3-position. This arrangement confers distinct reactivity and binding capabilities, making it a promising candidate for further exploration in drug discovery and molecular recognition studies. The presence of both polar and non-polar regions in its structure allows for interactions with various biological targets, including proteins and nucleic acids.

In recent years, there has been growing interest in the development of bisbenzyl derivatives as pharmacological agents due to their potential to modulate biological pathways involved in diseases such as cancer, inflammation, and neurodegeneration. The acetyl group in 5-Acetyl-3-aminoiminodibenzyl can serve as a point of modification for further derivatization, enabling the creation of libraries of compounds with tailored biological activities. Additionally, the aminoimine functionality provides a site for hydrogen bonding and coordination interactions, which are crucial for binding to biological macromolecules.

One of the most compelling aspects of 5-Acetyl-3-aminoiminodibenzyl is its utility as a building block in medicinal chemistry. Researchers have leveraged its scaffold to design molecules that exhibit inhibitory effects on enzymes and receptors implicated in various therapeutic areas. For instance, studies have shown that derivatives of this compound can interact with kinases and transcription factors, potentially leading to the development of treatments for metabolic disorders and oncological conditions. The versatility of 5-Acetyl-3-aminoiminodibenzyl lies in its ability to be functionalized in multiple ways, allowing chemists to explore diverse chemical space.

The synthesis of 5-Acetyl-3-aminoiminodibenzyl involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Common synthetic routes include condensation reactions between appropriate precursors followed by functional group transformations such as acetylation and imination. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to obtain sufficient quantities for both laboratory-scale investigations and preclinical studies.

Recent research has highlighted the potential applications of 5-Acetyl-3-aminoiminodibenzyl in computational chemistry and molecular modeling. Its well-defined structure allows for accurate docking studies, which are essential for predicting how it might interact with biological targets. By integrating experimental data with computational predictions, scientists can accelerate the discovery process and prioritize compounds for further validation. This interdisciplinary approach has been instrumental in identifying lead candidates for drug development programs.

The pharmacokinetic properties of 5-Acetyl-3-aminoiminodibenzyl are also under investigation to assess its suitability for therapeutic use. Factors such as solubility, stability, and metabolic clearance play critical roles in determining whether a compound can reach its target site effectively within an organism. Preliminary studies suggest that modifications to the dibenzyl core can influence these properties significantly, offering opportunities to optimize bioavailability and reduce off-target effects.

In conclusion, 5-Acetyl-3-aminoiminodibenzyl (CAS No. 84803-67-8) represents a fascinating compound with broad applications in chemical biology and pharmaceutical research. Its unique structural features provide a rich foundation for designing molecules with therapeutic potential, while ongoing studies continue to uncover new ways to harness its capabilities. As research progresses, it is likely that this compound will play an increasingly important role in the development of next-generation drugs targeting complex diseases.

• 13080-75-6(5-Acetyl-10,11-dihydro-5H-dibenzob,fazepine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)